New Screening Tool IDs 95 Percent of Stage 1 Pancreatic Cancer

Scott Lippman, MD, is director of the UC San Diego Moores Cancer Center and co-senior author of a new <em>Nature Communications Medicine</em> paper about a study showing that high-conductance di-electrophoresis detected 95 percent of early pancreatic cancers.

Credit: UC San Diego Health Sciences

Scott Lippman, MD, is director of the UC San Diego Moores Cancer Center and co-senior author of a new Nature Communications Medicine paper about a study showing that high-conductance di-electrophoresis detected 95 percent of early pancreatic cancers.

« New Screening Tool IDs 95 Percent of Stage 1 Pancreatic Cancer

Credit: UC San Diego Health Sciences

Andrew Lowy, MD, clinical director for Cancer Surgery at UC San Diego Health Moores Cancer Center.

« New Screening Tool IDs 95 Percent of Stage 1 Pancreatic Cancer

Expert Pitch

Expert Query

Expert Directory